1-2 of 2
Keywords: Family history
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The CHEK2 *1100delC Mutation and Adolescent Breast Cancer: A Case Report of Breast Cancer in a 19-Year-Old and a Review of the Literature

Available to Purchase
Subject Area:
Oncology , Women's and Children's Health
Tahereh Soleimani, Abigail J. Engwall, Corrie Bourdon, Mohammad A. Torabi, Thais Fortes
Journal: Breast Care
Breast Care (2022) 17 (1): 85–89.
https://doi.org/10.1159/000513679
Published Online: 08 March 2021
... is an uncommon genetic variant with a reported incidence of 0.3–1.6% in the general population and 4.9–5.7% in those with a family history of BC. Commonly, this mutation presents in females of European descent and is rare in North America. Case Presentation: A 19-year-old Caucasian female presented with breast...
View articletitled, The CHEK2 *1100delC Mutation and Adolescent Breast Cancer: A Case Report of Breast Cancer in a 19-Year-Old and a Review of the Literature
Open the PDF for The CHEK2 *1100delC Mutation and Adolescent Breast Cancer: A Case Report of Breast Cancer in a 19-Year-Old and a Review of the Literature in another window
Journal Articles

Influence of Family History of Breast or Ovarian Cancer on Pathological Complete Response and Long-Term Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

Available to Purchase
Subject Area:
Oncology , Women's and Children's Health
Marius Wunderle, Lothar Häberle, Alexander Hein, Sebastian M. Jud, Michael P. Lux, Carolin C. Hack, Julius Emons, Felix Heindl, Naiba Nabieva, Christian R. Loehberg, Rüdiger Schulz-Wendtland, Arndt Hartmann, Matthias W. Beckmann, Peter A. Fasching, Paul Gass
Journal: Breast Care
Breast Care (2021) 16 (3): 254–262.
https://doi.org/10.1159/000507475
Published Online: 01 July 2020
..., a pathological complete response (pCR) has been described as generally resulting in a favorable prognosis. However, there are subgroups, such as patients with a mutation in BRCA1 or BRCA2 ,in which the effect of pCR on the prognosis is suspected to be weaker. Patients with a family history of breast...
View articletitled, Influence of Family History of Breast or Ovarian Cancer on Pathological Complete Response and Long-Term Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Open the PDF for Influence of Family History of Breast or Ovarian Cancer on Pathological Complete Response and Long-Term Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy in another window